In a groundbreaking European initiative poised to redefine supportive care in oncology, the RELEVIUM project launches a multicenter randomized controlled…
Europe’s leading cancer conference may be swimming in antibody-drug conjugate (ADC) data, but AstraZeneca remains convinced that its in-house pipeline…